MTOR and myocardial infarction: PRAS40 in conjunction with mTOR is closely associated with diabetes, cardiovascular diseases, and neurological diseases, such as improving insulin sensitivity [30], decreasing cardiomyocyte apoptosis after myocardial infarction [31] and neuroprotectivity after transient focal cerebral ischemia [32].